The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study. (Q53620115)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

0 references

atrial fibrillation

0 references

0 references

Johan Lindbäck

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

Christopher B. Granger

13

object named as

Christopher B Granger

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

14

object named as

Lars Wallentin

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

Agneta Siegbahn

11

object named as

Agneta Siegbahn

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

John W. Eikelboom

6

object named as

John W Eikelboom

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

8

object named as

Claes Held

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

12

object named as

Salim Yusuf

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

2

object named as

Jonas Oldgren

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

Renato Delascio Lopes

10

object named as

Renato D Lopes

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

John H. Alexander

4

object named as

John H Alexander

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

Michael D. Ezekowitz

7

object named as

Michael D Ezekowitz

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

9

object named as

Elaine M Hylek

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

1

object named as

Ziad Hijazi

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

ARISTOTLE and RE-LY Investigators

15

object named as

ARISTOTLE and RE-LY Investigators

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

author name string

Stuart J Connolly

5

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

language of work or name

0 references

publication date

4 April 2016

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

387

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

10035

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

2302-2311

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARI

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Biomarkers in atrial fibrillation: a clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Apixaban versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Towards better clinical prediction models: seven steps for development and an ABCD for validation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

External validation of a Cox prognostic model: principles and methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2900741-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(16)00741-8

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/27056738

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53620115&oldid=1744019142"